EUVIMEDEUVIMED entdecken
Crossref

Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines

Yi Liu, Miho Suzuoki, Hiroki Tanaka, Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b23-00689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Yi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles, Liposomes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA vaccines based on Lipid nanoparticles (LNP) were put into practical use within only one year after the global outbreak of the coronavirus disease 2019 (COVID-19). This success of RNA vaccine highlights the utility of an mRNA delivery system as a vaccination strategy. Potent immunostimulatory activity of LNPs (i.e., inflammation occurring at the injection site and the production of inflammatory cytokines) have recently been reported. However, we have only limited knowledge concerning which cells are responsible for responding to the LNPs. We report herein on in vitro chemokine production from non-immune cells in response to exposure to LNPs. In this study, SM-102, an ionizable lipid that is used in the approved RNA vaccine for the clinical usage of COVID-19 mRNA vaccine, was used. Immortalized mouse lymphatic endothelial cells (mLECs) or professional antigen presenting cells (APCs) such as RAW 264.7 monocyte/macrophage cells were incubated with LNPs that contained no mRNA. As a result, chemokines involved in the recruitment of monocytes/neutrophils were produced only by the mLECs following the LNP treatment. These findings indicate that LEC appear to serve as the cell that sends out initial signals to response LNPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NanoparticlesLiposomesAnimalsHumansMicemRNA VaccinesCOVID-19 VaccinesEndothelial CellsChemokinesRNA, MessengerRNA, Small Interfering

Stichwörter der Autor:innen

RNA vaccinechemokineinflammationlipid nanoparticlelymphatic endothelial cell

Substanzen

Lipid NanoparticlesmRNA VaccinesCOVID-19 VaccinesChemokinesRNA, MessengerRNA, Small InterferingLiposomes

Autor:innen und Institutionen

  • Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University.
  • Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University.

Zitieren

APA

Liu, Y., Suzuoki, M., Tanaka, H., Sakurai, Y., Hatakeyama, H., & Akita, H. (2024). Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00689

Vancouver

Liu Y, Suzuoki M, Tanaka H, Sakurai Y, Hatakeyama H, Akita H. Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00689

BibTeX
@article{Liu2024,
  author = {Liu, Yi and Suzuoki, Miho and Tanaka, Hiroki and Sakurai, Yu and Hatakeyama, Hiroto and Akita, Hidetaka},
  title = {Lymphatic Endothelial Cells Produce Chemokines in Response to the Lipid Nanoparticles Used in RNA Vaccines},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b23-00689}
}
Kostenlos starten →